Vertex Pharmaceuticals (Germany) GmbH
General information
Vertex Pharmaceuticals (Germany) GmbH
Sonnenstr. 19/Zugang 2
2. Stock
80331 München, Bavaria
Germany
Contact person: Nawal (Bencherif) Peacock, Regional Vice President
Company main phone: +49 (89) 20602-9900
Company main fax: +49 (89) 20602-9907
Website: https://www.vrtx.de/
Sonnenstr. 19/Zugang 2
2. Stock
80331 München, Bavaria
Germany
Contact person: Nawal (Bencherif) Peacock, Regional Vice President
Company main phone: +49 (89) 20602-9900
Company main fax: +49 (89) 20602-9907
Website: https://www.vrtx.de/
| Year founded: | 2011 |
| Source of foundation: | Subsidiary |
| Name of foundation source: | Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) |
Corporate description / mission:
Vertex is a global biotechnology company that aims to discover, develop and commercialize new medicines. Vertex Pharmaceuticals GmbH is responsible for commercial operations in Germany, Austria, Switzerland and Eastern Europe. The company primarily targets the core of serious and rare diseases such as cystic fibrosis.
Vertex is a global biotechnology company that aims to discover, develop and commercialize new medicines. Vertex Pharmaceuticals GmbH is responsible for commercial operations in Germany, Austria, Switzerland and Eastern Europe. The company primarily targets the core of serious and rare diseases such as cystic fibrosis.
State of ownership: Subsidiary
Headquarters: No
Headquarters: No
Categorization
| Sector: |
|
| Subsector: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
Summary Products / Services / Technologies
Description of products:
SYMKEVI (tezacaftor/ivacaftor)
ORKAMBI (lumacaftor/ivacaftor)
KALYDECO (ivacaftor)
KAFTRIO (ivacaftor/tezacaftor/elexacaftor)
SYMKEVI (tezacaftor/ivacaftor)
ORKAMBI (lumacaftor/ivacaftor)
KALYDECO (ivacaftor)
KAFTRIO (ivacaftor/tezacaftor/elexacaftor)
© 2023 Biotechgate by Venture Valuation